Semantic Feature Analysis Treatment for Aphasia

MM
MS
AA
Overseen ByAlyssa Autenreith, M.A.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: VA Pittsburgh Healthcare System
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests two versions of a treatment called Semantic Feature Analysis, which helps people with aphasia improve their ability to name things. Aphasia, often caused by a stroke, is a language disorder that makes speaking or understanding words difficult. Researchers aim to determine which version of the treatment works better and how it affects the brain. Ideal candidates for this trial include individuals who experienced a left-side stroke causing aphasia at least six months ago and can manage daily tasks independently or with assistance. Participants should not have other neurological issues and must not be in any other speech therapy during the study. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could enhance future aphasia treatments.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. However, it does require that you do not participate in any other speech-language treatment during the study.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that Semantic Feature Analysis (SFA) is an effective method for helping people with aphasia, a language disorder. This therapy targets naming difficulties, which are common in aphasia.

Studies have found that SFA is generally well-received. For example, one study found that participants who underwent SFA therapy improved their ability to name items by about 20% for practiced items. This suggests that SFA can be both safe and effective for enhancing language skills in people with aphasia.

These studies have reported no major side effects, highlighting the safety of SFA for people with aphasia. As a form of speech therapy rather than a new drug, this treatment generally carries lower risks compared to medication-based treatments.12345

Why are researchers excited about this trial?

Researchers are excited about the Semantic Feature Analysis (SFA) Treatment for aphasia because it offers a unique approach to improving language abilities. Unlike traditional speech therapy that may focus broadly on communication skills, SFA specifically enhances the patient's ability to retrieve and produce words by exploring their semantic features—like what a word looks like or how it's used. This trial compares a modified version of SFA with the standard approach, potentially leading to more personalized and effective interventions for people with aphasia. By targeting the cognitive processes involved in word retrieval, SFA could offer faster and more robust improvements in language function.

What evidence suggests that this trial's treatments could be effective for aphasia?

Studies have shown that Semantic Feature Analysis (SFA) helps people with aphasia improve their naming abilities. It tends to work better for those with fluent aphasia, but it can also benefit those with non-fluent aphasia. Research indicates that most participants find it easier to name objects they previously struggled with after using SFA. While results can vary, the treatment generally leads to positive outcomes. This trial will compare two versions of SFA: a modified version for one group of participants and a standard version for another group, to determine which is more effective.678910

Who Is on the Research Team?

WD

William D Hula, Ph.D.

Principal Investigator

VA Pittsburgh Healthcare System

PJ

Patrick J Doyle, Ph.D.

Principal Investigator

VA Pittsburgh Healthcare System

Are You a Good Fit for This Trial?

This trial is for individuals who have aphasia due to a stroke in the left side of their brain, at least 6 months ago. They must be able to manage daily activities on their own or with help from a caregiver, and not have uncontrolled health issues like seizures. Participants should speak English as their first language and not be involved in other speech treatments during the study.

Inclusion Criteria

Sufficient auditory comprehension abilities demonstrated during screening
I am not participating in any other speech therapy during this study.
It's been 6 months since my stroke, which caused speech issues.
See 4 more

Exclusion Criteria

You have a serious mental health condition.
You are currently dependent on drugs or alcohol.
You have a serious problem with speaking or moving.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants receive 60 hours of Semantic Feature Analysis treatment over a five-week period

5 weeks
Daily sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment, including language, eye-tracking, and fMRI testing

8 to 12 weeks post intervention
2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • Semantic Feature Analysis Treatment
Trial Overview The study tests two versions of Semantic Feature Analysis treatment for naming impairments caused by aphasia. It's a randomized controlled trial where participants are assigned randomly to one of the two treatment groups to see which is more effective.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: SFA Experimental InterventionExperimental Treatment1 Intervention
Group II: SFA Active Comparator InterventionActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Pittsburgh Healthcare System

Lead Sponsor

Trials
36
Recruited
15,900+

Penn State University

Collaborator

Trials
380
Recruited
131,000+

Published Research Related to This Trial

Semantic Feature Analysis (SFA) has been shown to improve naming abilities in 81.82% of participants with aphasia, based on a review of 21 studies involving 55 individuals.
The studies reviewed demonstrated a small treatment effect, indicating that while SFA is beneficial, further research is needed to better understand its efficacy and how well improvements generalize to everyday communication.
A Systematic Review of Semantic Feature Analysis Therapy Studies for Aphasia.Efstratiadou, EA., Papathanasiou, I., Holland, R., et al.[2019]
The study demonstrated that a working memory and modified Semantic Feature Analysis approach was successfully completed by all three participants with mild to moderate aphasia, indicating its feasibility for this population.
Participants showed significant improvements in naming performance and working memory abilities after treatment, suggesting that this approach may effectively help remediate word finding deficits in individuals with aphasia.
Using a combined working memory - Semantic feature analysis approach to treat anomia in aphasia: A Pilot Study.Hashimoto, N.[2023]
The modified semantic feature analysis (SFA) treatment combined with metacognitive strategy training (MST) showed positive effects on word retrieval accuracy in individuals with aphasia, with participants experiencing small to medium improvements in retrieving both treated and related words after 24 sessions.
The incorporation of MST into SFA also led to increased independent use of strategies for communication, suggesting that this combined approach not only helps with word retrieval but also encourages individuals to apply learned strategies in real-life situations.
Incorporating Metacognitive Strategy Training Into Semantic Treatment Promotes Restitutive and Substitutive Gains in Naming: A Single-Subject Investigation.Tilton-Bolowsky, VE., Brock, L., Nunn, K., et al.[2023]

Citations

1.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/29710193/
A Systematic Review of Semantic Feature Analysis ...Conclusions: SFA leads to positive outcomes despite the variability of treatment procedures, dosage, duration, and variations to the traditional ...
The Effectiveness of Semantic Feature AnalysisThe findings also suggest that semantic feature analysis is more effective for individuals with fluent aphasia than non-fluent aphasia. However, authors noted ...
The effectiveness of semantic feature analysisSemantic feature analysis was an effective intervention for improving confrontational naming for the majority of participants included in the current review.
Semantic Feature Analysis Treatment for AphasiaThis study will provide theoretically and clinically relevant information about how aphasia treatment should be delivered and the neurocognitive mechanisms ...
Outcomes of semantic feature analysis treatment for ...SFA has been found to be effective for improving naming of treated nouns in people with aphasia, but there is mixed evidence supporting ...
6.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/33590683/
Outcomes of semantic feature analysis treatment for ...This study compares the effects of SFA in a group of individuals with aphasia alone and a group with similar severity of aphasia but with concomitant AOS.
Semantic Feature Analysis Treatment for AphasiaThis randomized controlled comparative effectiveness study examines manipulation of a key component of an established and efficacious treatment for naming ...
High-Frequency Language Therapy with Semantic Feature ...Two weeks after therapy, naming accuracy increased by an average of 20% for trained items, whereas it did not change for untrained items. Naming ...
Comparing Traditional Semantic Feature Analysis (tSFA) ...Researchers will compare outcomes between these two treatments to see if SFA+MST yields larger effects in picture naming and spontaneous speech outcomes than ...
A discourse-based approach to semantic feature analysis ...Semantic feature analysis was applied to object and action word retrieval failures appearing during picture descriptions and procedural questions.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security